| Execution period | Exercisable within 1 year from vesting |
|---|
BSE filing, NSE: SGFIN. Summary written from the filing by ALFA Finder's alert engine.
SG Finserve Ltd: key numbers
- Share price
- ₹651.35
- Market cap
- ₹4,359 Cr
- Revenue (annual)
- ₹333.4 Cr
- Net profit (annual)
- ₹127.7 Cr
- P/E (TTM)
- 23.3×Sector 19.7×
- Promoter holding
- 56.95%+0.00% QoQ
- FII holding
- 1.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SG Finserve Ltd
All →SG Finserve Acquisition Worth ₹4.65 Cr
SG Finserve Limited is acquiring a 15.50% stake in Successship Technologies Private Limited for ₹4.65 Crore to enhance its in-house AI and digital capabilities.
- Value
- ₹4.65 Cr
SG Finserve Acquisition Worth ₹0.01 Cr
SG Finserve Limited will acquire an equity stake in SG Enterprise Solutions Private Limited for Rs. 0.01 Crore to establish a group shared services model.
- Value
- ₹0.01 Cr
- Execution
- 31-12-2026
SG Finserve Management Change
SG Finserve Limited has appointed Mr. Alok Bhushan as Internal Auditor for a three-month term, following the resignation of Mr. Saurabh Mishra.
SG Finserve Investor Presentation: Key Takeaways
SG Finserve reported record Q2FY27 performance with PAT reaching ₹59 Cr. The company is scaling its supply chain finance ecosystem, with 75% of the loan book now outside the APL Apollo Group.
- Call
- Guides 32% growth
SG Finserve Q2 FY27 Results: Net Profit ₹58.8 Cr, Up 107.0% YoY
SG Finserve Ltd reported revenue from operations of ₹160.9 Cr (+115.4% YoY) and net profit of ₹58.8 Cr (+107.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹58.8 Cr · +107.0% YoY
SG Finserve Board Meeting Date
SG Finserve Limited has scheduled a board meeting on 16 October 2026 to consider and approve its standalone and consolidated financial results for the half-year period.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date